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Abstract
Although many promising objective methods (measuring systems) are available, there are no
truly validated instruments for monitoring intensive care unit (ICU) sedation. Auditory evoked
potentials can be used only for research in patients with a deep level of sedation. Other
measuring systems require further development and validation to be useful in the ICU.
Continuing research will provide an objective system to improve the monitoring and
controlling of this essential treatment for ICU patients. Subjective methods (scoring
systems) that are based on clinical observation have proven their usefulness in guiding
sedative therapy. The Glasgow Coma Score modified by Cook and Palma (GCSC) achieves
good face validity and reliability, which assures its clinical utility for routine practice and
research. Other scales, in particular the Ramsay Scale, can be recommended preferably for
clinical use. An accurate use of available instruments can improve the sedative treatment
that we deliver to our patients.
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Introduction
Anxiety and agitation are experienced by more than 70%
of ICU patients. Their prevalence is even greater in criti-
cally ill patients undergoing mechanical ventilation. Conse-
quently, the routine assessment of sedation should be a
part of total care for critically ill patients, in a manner
similar to that in which cardiorespiratory parameters are
monitored. The difficulty in monitoring sedation, however,
is that there is no gold standard tool for this purpose [1].
Current techniques have been proposed, but they are
often not supported by conclusive clinical evidence. A crit-
ical review of the available studies reveals three methodo-
logical problems. The first is the fact that these instru-
ments have commonly been tested in postoperative
patients, who do not suffer the multiple organ disorders
experienced by critically ill patients [2]. Second, much of
the available medical literature is based on the opinions of
experts, rather than on results of controlled clinical trials.
Finally, the third problem is the weak design of most of the
published studies, which are often poorly controlled and
nonrandomized. So far there have only been two reported
trials that have employed a double-blind protocol [3]. It is
therefore not surprising that routine sedation is often an
empirical clinical exercise, without adequate assessment
according to scientific evidence.Critical Care    Vol 4 No 4 Carrasco
The clinical utility of each available tool must be evaluated
rigorously before deciding on whether they have applica-
tions in routine practice, because assessment of sedation
is a primary objective in intensive care management.
From both practical and evidence-based points of view,
the present review assesses the available instruments
for monitoring and controlling sedation in ICU patients
who are undergoing mechanical ventilation. It is struc-
tured in two parts. The first part introduces some
methodological concepts to facilitate a critical review of
each instrument. The second part provides practical
recommendations, on the basis of evidence and experi-
ence, for a clinical approach to the application of each
tool in ICU settings.
Methodological concepts regarding the
assessment of sedation
Considerations concerning validity and reliability of
instruments
The clinical utility of each new instrument should be
assessed according to a rational evaluation of its validity,
reliability and applicability.
‘Validity’ is the ability of a tool to actually measure the
parameter that it is designed for. In monitoring of sedation
this concept implies the ability to document agitation and
distress symptoms (anxiety, delirium and pain), as well as
to identify the end-points of each level of sedation that
each sedative agent can achieve. It is indispensable also
that it measures the reality from an interpretation scheme
with validity on both content and construct in order to
ensure that the same clinical situations will always be
interpreted in the same way.
If a standard criterion exits, then the new test should
compare favourably with it. The ‘gold standard’ is easy to
define for some conditions, but is more much elusive when
testing diagnosis of subjective experiences such as
anxiety or agitation. For this reason, the validation of these
instruments is more much difficult and complex. Accord-
ingly, validity tends to be confirmed on the basis of opinion
of recognized practitioners (face validity) searching for
signs and symptoms as logical consequences (or con-
structs) of the target disorders.
‘Reliability’ is the capacity of a new test to obtain similar
measures with different observers (inter-rater) or with the
same observer at different times (intrarater). In clinical
research, interobserver agreement (calculated as
weighted  k index) is the best indicator of the reliability of
these instruments.
‘Applicability’ in this context implies that an instrument is
easy to learn to operate, and that it is suitable for routine
use by physicians and nurses.
In order to assist the reader in determining the relative
methodological authority of the evidence presented
herein, a rating system is employed that facilitates objec-
tive analysis (Table 1) [1].
Considerations regarding clinical and experimental
evidence
The technical assessment of each instrument should not
only be subjected to a critical analysis of its methodology,
but also to a review of the quality of the studies on which it
has been based. This is essential in order to make a cri-
tique of the advantages and limitations of such instru-
ments. The quality of these studies can be classified
according to three categories:
(1) class I evidence – the instrument has been validated
by one or more double-blinded, or randomized con-
trolled clinical trials carried out in an adequate sample
of critically ill patients;
(2) class II evidence – the instrument has been validated
according to data provided by one or more adequately
designed and controlled clinical studies, but not in crit-
ically ill patients; and
(3) class III evidence – the instrument has not been vali-
dated or has only been validated on the basis of
experts’ opinions, studies with historical controls, or
case reports.
The references have been qualified according to the clas-
sification described above.
Rational scheme for adjusting doses of sedatives
Sedation level should be assessed on a continuous basis
for each instrument. Three levels of sedation can be con-
sidered: adequate – sedation is measured accurately
within the desired range; insufficient – the measured level
of sedation is lower than the actual level of sedation,
within the desired range; and excessive – the measured
level of sedation is higher than the actual level of sedation,
within the desired range. It is critical that the level of seda-
tion is measured accurately, because if the measured level
is insufficient or excessive, then the intravenous infusion
will be increased or decreased (Fig. 1).
Adequacy of sedation in ICU settings: individualized level
of sedation
The vast majority of experts agree that the adequate level
of sedation level is different for each patient, according to
their different clinical circumstances (severity of the respi-
ratory insufficiency, haemodynamic state, etc) [4,5]. In
addition, the different definitions of the ideal levels of
sedation are only the opinions of investigators, and are not
necessarily based on experimental evidence. For this
reason, these subjective concepts are not applicable to
the general population of critical care patients. Neverthe-
less, the concept that must be emphasized is the need for
sedation to be applied on an individualized basis, underhttp://ccforum.com/content/4/4/217
the clinical criteria of intensivists, because any definition is
valid for all the sedation needs that our patients require in
daily practise.
There are recent contributions to this topic. The most
remarkable is the study of Kress et al [6]. Those investiga-
tors suggested that the interruption of sedation can in
some patients reduce the necessary time of mechanical
ventilation. Also, in the methodology of this work is that it
is the intensivist who must decide which patients can be
awakened. Each physician also decides the adequate
level of sedation for each patient included in the study. I
agree with the author in considering that sedation must be
adjusted in an individualized way. This approach is cur-
rently the best way to administer sedation.
Quality of sedation
Undersedation and oversedation cause several problems.
Undersedation usually produces sudden changes in the
level of consciousness as a consequence of stress. This
changes results in inadequate ventilation, hypertension,
tachycardia and discomfort, all of which have adverse con-
sequences for the outcome of ICU patients [7]. Overseda-
tion often occurs as a result of accumulation of sedative
and analgesic agents, and it can be associated with pro-
longation of mechanical ventilation and weaning [8].
To avoid these problems a reliable definition of quality of
sedation is necessary. This concept should be defined as
the percentage of hours in which a patient maintains an
adequate or desired level of sedation according to the
assessment method used [9]:
adequate sedation hours
Quality of sedation =                                              × 100
total hours of sedation 
Thus, quality of sedation is expressed as a percentage. A
reasonable goal is to achieve a quality of sedation greater
than 85% [9]. To have a method to measure the quality of
sedation is as important as choosing the best instrument.
Practical recommendations
Assessments systems for sedation
The methods that are suitable for assessing the depth of
sedation can be considered under two headings – objec-
tive or subjective assessment – depending on whether the
techniques require the application of an index that is
derived from a quantifiable physiological variable (mea-
surement system) or of a scoring system, respectively [5].
Objective methods: sedation measuring systems
The development of methods for objective measurement
of sedation has paralleled the development of methods for
assessment of the depth of surgical anaesthesia. In addi-
tion, the available equipment has been developed from
technology used in anaesthesia. Unfortunately, none of
these measures has been validated for clinical use in the
ICU [11]. Most of them are in the process of development
and validation. However, they may be used as alternatives
in sedated patients for whom sedation scores cannot be
Table 1
Rating system to determine the clinical utility of instruments for monitoring ICU sedation
Condition Description Points
Validity Capacity to document agitation- and distress-related symptoms (pain, anxiety, delirium) 0–5
Content and construct validity 0–10
Exact definition of level of sedation end-points  0–10
Reliability Inter-rater and intra-rater agreement 0–20
Applicability Easy learning and routine recording by physicians and nurses 0–5
Total points 0–50
Figure 1
Rational scheme for adjusting doses of sedatives
INSUFFICIENT
EXCESSIVE
ADEQUATE LEVEL OF
SEDATION
Increase 10–20%  infusion
supplementary
doses of sedatives ±
infusion doses of sedative
Decrease 10–20%applied. Table 2 illustrates the characteristics and rating
classifications of these methods.
Plasma drug concentration
Although monitoring of therapeutic drug concentrations is
useful for antibiotics, anticonvulsants and antiarrythmics,
there is no correlation between plasma concentration and
the effect of a drug at its site of action. In contrast to post-
operative patients, critically ill patients often have continu-
ously varying degrees of organic dysfunction that lead to
alterations in their responses to drugs (pharmacodynam-
ics) and in their ability to eliminate drugs by biotransforma-
tion and excretion (pharmacokinetics). Sample processing
delays before results are available result in an inadequate
reference on which to base adjustment of sedation. A
further limitation pertains to interindividual variation in the
sedative effects of some agents, such as benzodi-
azepines. High plasma concentrations of midazolam have
been associated with an increase in agitation [12]. Conse-
quently, this method cannot be recommended for monitor-
ing sedation in daily practice.
Frontalis electromyogram
The frontalis muscle contracts in response to stress, and
this contraction can be recorded even in the presence of
neuromuscular blocking agents. This method was used by
Edmonds et al [13] to monitor anaesthesia. Unfortunately,
this technique is not sufficiently sensitive for the purpose
of monitoring the level of sedation in ICU patients.
Lower oesophageal contractility
Evans et al [14] observed a correlation of peristaltic con-
tractility with depth of anaesthesia. Spontaneous lower
oesophageal contractility represents a response to stress.
However, this response is subject to considerable interpa-
tient variation, and it may also be influenced by atropine.
Continuous electroencephalography
This method was proposed by Peter [15] 50 years ago for
monitoring of opiate intravenous anaesthesia. It provides a
record of cortical activity, measured from a series of scalp
electrodes, against time. Decreases in the level of con-
sciousness result in changes in electroencephalography
readings. However, different sedatives alter the readings
in different ways, making interpretation very difficult. In
addition, electroencephalography does not correlate with
sedation score or plasma drug concentration [11].
In centres that have experience in collecting electroen-
cephalography records, this information can be useful in
interpreting neurological function in patients after head
injury or in evaluating coma versus brain death. However,
continuous electroencephalography cannot be recom-
mended for routine monitoring of ICU sedation.
Cerebral function monitor
The cerebral function monitor was described by Dubois et
al [16] for the purpose of monitoring the level of general
anaesthesia. It is a device that processes electroen-
cephalography readings, but remains in time domain. The
electroencephalography is filtered to minimize the impact
of low frequency activity and is rectified to eliminate its
biphasic value. The electrical activity is recorded from one
channel, and is displayed as a low-speed paper trace.
The adequacy of the cerebral function monitor has not
been confirmed in critically ill patients because it is drug
dependent [13]. For this reason, the cerebral function
monitor cannot be recommended for clinical use.
Cerebral function analyzing monitor
This system uses two electroencephalography channels. It
was used by Sebel et al [17] to monitor the depth of
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Table 2
Characteristics of measurement systems
Clinical utility
Measuring system Advantages and limitations (rating points 0–50) Reference
Plasma drug concentration Lack of agreement with level of sedation 5 [10]
Frontalis electromyography Interindividual variation 10 [11]
Lower oesophageal contractility Low sensitivity 10 [12]
Continuous electroencephalography Difficult interpretation 15 [13]
Interagent variation
Cerebral function monitor Complex and difficult to interpret 20 [14]
Cerebral function analyzing monitor Complex and difficult to interpret 25 [15]
Power spectral analysis Not available for clinical use 5 [16]
AEPs Limited reliability in light sedation 35 [17]
Adequate for researchanaesthesia. It produces information that is easy to inter-
pret and that varies with depth of sedation. It is not as yet
available for daily practice. Further studies are necessary
to validate the use of this device in ICU settings.
Power spectral analysis
This technique employs an alternative analysis of the elec-
troencephalography signal. The signal is digitized at fixed
time, analyzed and subjected to power-spectrum calcula-
tion. Vesalis et al [18] described a correlation between
spectral edge frequency and sedation with midazolam in
ICU patients. Recently, the median frequency has been
used to regulate a closed loop of total intravenous anaes-
thesia. This finding has not been confirmed in patients
with more severe organic dysfunction [18]. The utility of
this technique in critically ill patients remain unknown.
Sensory evoked potentials
Evoked potentials (EPs) are electrophysiologic responses
of the nervous system to sensory stimulation. A computer
is used to average individual time-locked responses to
repeated stimuli. EPs are divided into three classes on the
basis of latency. Long-latency EPs (hundreds of millisec-
onds) are suppressed under surgical anaesthesia, and are
not useful for monitoring of sedation. Medium-latency EPs
(tens of milliseconds) are often recordable under anaes-
thesia, and can be affected by anaesthetic state. Short-
latency EPs (milliseconds), which are predominantly
generated at subcortical levels, are sufficiently strong to
be recorded under sedation.
The auditory evoked potentials (AEPs) are the simplest
EPs to produce. Auditory stimulation is accomplished with
filtered clicks delivered by headphones. EPs are recorded
from scalp electrodes in response to a standard noise. 
There is clinical evidence regarding the clinical utility of
AEPs for monitoring of sedation. A recent study [19] corre-
lated this method with the results from five different scoring
systems. Further studies are required to validate the use of
AEPs in monitoring of sedation. AEPs can only be recom-
mended for research in patients with deep levels of seda-
tion, because light levels of sedation resulted in AEPs that
are poorly correlated with scoring system results (Fig. 2).
The clinical utilities of other types of evoked response
(motor or visual) have not been demonstrated.
Subjective methods: scoring systems
The only instruments that have demonstrated usefulness
in the critical care setting are the scoring systems that are
widely known as scales of sedation [18]. These instru-
ments are based on clinical observation. The scores are
recorded according to direct evaluation by an observer.
Each scale should be validated according to the training
and characteristics of the professionals that use it.
Interobserver agreement (calculated as weighted k index) is
the most important feature in assessing scales of sedation.
It is also desirable that other characteristics are included in
the assessment, such as simplicity, reliability, accuracy and
minimal additional discomfort to the patient [20].
There is no ideal scoring system. More than 30 clinical
scales have been described in the medical literature.
However, only two of these instruments have been ade-
quately validated for use in the ICU: the Ramsay scale and
the GCSC. Because there is no goal standard against
which to validate the sedation scales, researchers have tar-
getted their investigations at determining the ‘clinimetric’
properties of these scales. De Jonghe et al [21], in a recent
systematic review, observed the high reliability and satis-
factory correlation with other scales achieved by the
Ramsay scale and Comfort scale. The only limitation
observed was the lack of studies that validated these scale
in detecting changes in the sedation status over time.
Ramsay scale
This scoring system was described by Ramsay et al [22]
in 1974 for the purpose of monitoring sedation with
alphaxolone/alphadolone. It continues to be the most
widely used scale for monitoring sedation in daily practice,
as well as in clinical research.
This instrument identifies situations of agitation or sleep
visually (Table 3). Some experts consider that it is more a
scale of consciousness than a tool for measurement of
sedation [23]. Those authors have also suggested that the
http://ccforum.com/content/4/4/217
Figure 2
Correlation between AEPs (low latency Nb) and scoring system (more
than 10 points corresponds to deep sedation).
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Nb (ms)sedation levels identified using this scale are not clearly
defined or fully conclusive. Consequently, they consider
that this scale is excessively subjective and that it has
poor validity.
Contrary to these opinions, in our experience this method
has good reliability, with good interobserver agreement
(Cohen k index 0.79; P<0.0001) [24]. This qualifies this
scale as sufficiently reproducible for clinical practice.
Glasgow Coma Scale modified by Cook and Palma
Described by Cook in 1987 [25], this instrument provides
a score of the reactivity of the patient under mechanical
ventilation according to response to external stimuli
(Table 4). Opening of the eyes is considered to be indica-
tive of higher functioning, and motor response is evaluated
on the basis of somatic stimulation. It causes minimal addi-
tional discomfort to the patient.
The above cited study [24] confirmed the reproducibility
of this scale, with good agreement between observers
(Cohen k index 0.94; P<0.0001) which validated it for
practice as well as for clinical research [13]. Fig. 3 illus-
trates these findings.
Bion scale
In 1988, Bion [26] designed a three-dimensional linear
analogue scale that combines evaluation of depth of seda-
tion and degree of distress (a level of comprehension of
consciousness). Although this system provides useful
information, it is too complex for use in daily practice.
Comfort scale
1994, Max et al [27] reported experience with a new desig-
nated scale in 85 mechanically ventilated children. Those
authors consider this scale to be sufficiently reliable, despite
the fact that discrepancies between observers were
observed in 38% of the measurements. The characteristics
of this method mean that it has little application in adults.
Sedation–agitation scale
This scoring system was described by Riker et al [28] for
the purpose of controlling treatment with haloperidol in
agitated ICU patients. It achieved good inter-rater correla-
tion (Cohen k index 0.92), but it does not evaluate the
relation between patient and ventilator. However, it is suffi-
ciently reproducible for use in clinical practice.
Critical Care    Vol 4 No 4 Carrasco
Table 3
Ramsay scale
Level Characteristics
1 Patient awake, anxious, agitated, or restless
2 Patient awake, cooperative, orientated and tranquil
3 Patient drowsy, with response to commands
4 Patient asleep, brisk response to glabella tap or loud auditory
stimulus
5 Patient asleep, sluggish response to stimulus
6 Patient has no response to firm nail-bed pressure or other 
noxious stimuli
Figure 3
Interobserver agreement in two sedation scales with two observers.
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( < 0.0001) P
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(P < 0.00001)
Table 4
Glasgow Coma Scale modified by Cook and Palma
Characteristic Score
Eyes open
Spontaneously 4
In response to speech 3
In response to pain 2
None 1
Response to nursing procedures
Obeys commands 5
Purposeful movements 4
Nonpurposeful flexion 3
Nonpurposeful extension 2
None 1
Cough
Spontaneous strong 4
Spontaneous weak 3
On suction only 2
None 1
Respiration 
Obeys commands 5
Spontaneous intubated 4
Spontaneous intermittent mandatory ventilator triggering 3
Respiration against ventilator 2
No respiratory efforts 1Motor activity assessment scale
This scale was described by Clemmer, and has recently
been evaluated in surgical ICU patients by Devlin et al
[29]. The reliability observed in this study was good
(Cohen  k index 0.83), but this agreement should be con-
firmed in critically ill patients.
Rational selection of sedation scales
All validated scales can be used in clinical practice.
However, for research purposes the GCSC [13] is prefer-
able. Table 5 summarizes the characteristics and rating
classification of sedation scales.
Practical recommendations to guide sedative therapy
according to ventilatory mode
The following recommendations are guidelines for special-
ists. There is, to my knowledge, only one published article
regarding this topic [30]. For this reason, the following
recommendations are based on my experience. Obviously,
the selection of treatment must be made according to clin-
ical judgement, adapting it to the clinical circumstances of
each patient. Table 6 summarize these recommendations.
Assisted-controlled mechanical ventilation
The traditional controlled mechanical ventilation (CMV)
mode does not permit synchronization between sponta-
neous breaths of the patient and the cycle of the respira-
tor. For this reason, modern ventilators have substituted
CMV with assisted CMV. The assisted CMV mode is more
flexible and permits spontaneous patient breathing at
some points in the cycle. This means that it is not neces-
sary for sedation to suppress totally the spontaneous
breathing of patient. Assisted CMV is the recommended
mode for initiating mechanical ventilation, because it
assures a specific minute volume even in the absence or
weakness of respiratory stimuli. Generally, this mode
achieves good synchronization between the ventilator
cycle and the effort of the patient.
In order to formulate the sedation regimen, two fundamen-
tal factors must be considered. First, the degree of patient
resistance must be evaluated. At present, we think that the
best approach is to maintain a light and comfortable level
of sedation, if it is reasonably possible, in order to
decrease the incidence of adverse effects of high doses
of sedatives. The ideal sedation depth for most of these
patients is mean sedation (level 3 of the Ramsay scale or
between 8 and 12 points of the GCSC).
The second factor is the anticipated duration of mechanical
ventilation. If it is anticipated that sedation of less than 24h
(short-term sedation) will be required, then both propofol or
midazolam should be selected. The initial dose of propofol
should be 1mg/kg, preceded by 1mg/kg as a bolus.
Adjustments to the dose should be made in 10–20% incre-
ments or decrements. Midazolam should be administered at
an initial dose of 0.1mg/kg, preceded by 0.05mg/kg as a
bolus. Adjustments to the dose should also be made in
10–20% increments or decrements. If the anticipated dura-
tion of sedation is between 24 and 72h (medium-term
sedation) then propofol is preferable to midazolam because
of the unnecessary accumulation and extended sedation
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Table 5
Characteristics of scoring systems
Scoring system Interoberver agreement Clinical utility (rating points 0–50) Reference
Ramsay scale 0.79 40 [19]
GCSC 0.94 45 [22]
Bion scale 0.45 30 [23]
Comfort scale Unavailable – [24]
Sedation–agitation scale 0.92 35 [25]
Motor activity assessment scale 0.83 35 [27]
Table 6
Recommendations to guide sedative therapy according to
ventilatory mode
Ventilatory mode Therapeutic goal Therapeutic goal
(Ramsay scale level) (GCSC points)
Assisted CMV (<24h) 3 8–12
Assisted CMV (24–72h) 3 8–12
Assisted CMV (>72h) 3 8–12
Pressure controlled ventilation 4–5 15–18
Synchronous intermittent 2 13–15
mandatory ventilation
Pressure support ventilation 2 13–15
Continuous positive airway 2 13–15
pressurethat can occur with this drug. Nevertheless, if midazolam is
used, then the dose should be titrated 12–24h before
sedation is due to be discontinued. If it is expected that
sedation will need to be sustained for longer than 3 days
(long-term sedation), then midazolam is preferable. Two
days before discontinuation of sedation, midazolam should
be substituted with propofol to facilitate elimination of the
benzodiazepines before the patient awakes.
Complementary analgesia will also be necessary in most
cases, because none of the available sedatives have anal-
gesic properties. In my opinion, analgesics should be
administered always if communication with the patient is
not possible. The initial plan should be to administer mor-
phine as a continuous infusion (0.5–1.5mg/kg perh), with
a supplementary bolus of 3–5 mg if indicated. Alterna-
tively, fentanyl may be used at equivalent doses.
Pressure controlled ventilation
Some authors have postulated that this ventilatory mode
can reduce the incidence of barotrauma, decreasing
airway pressure and alveolar overdistension. This mode
has been used in refractory hypoxaemia, and it has been
associated with other ventilatory techniques as the inver-
sion of the inspiration–expiration relationship or high fre-
quency ventilation. There are practical limitations to the
use of this mode because it can cause a degree of
patient–ventilator asynchrony, so most of the patients
need deep sedation (level 4–5 of the Ramsay scale or
8–12 points on the GCSC). The recommended sedation
regimen is the same as that for assisted CMV (see above).
Synchronized intermittent mandatory ventilation
This mode is a partial support system that requires preser-
vation of spontaneous breathing. It requires a degree of
cooperation from the patient. It is commonly used without
continuous sedation in patients who are being weaned
from mechanical ventilation.
Some patients ventilated in this manner require sedation
because of agitation as a result of nonrespiratory cause. If
it is necessary to administer sedatives, the patient should
be carefully monitored; if there is confusional symptoma-
tology, then a combined regimen of a sedative at a low
dose and a neuroleptic should be administered. The thera-
peutic goal is light sedation (level 2 of the Ramsay scale
or 13–15 points on the GCSC). For this purpose, propo-
fol is indicated at anxiolytic doses (0.5mg/kg perh, ini-
tially). Alternatively, midazolam can be used at a low dose
(0.05mg/kg perh), provided that the treatment is not
extended beyond than 24h. This combination achieves
excellent results in patients under assisted ventilation, and
it has little effect on respiratory stimuli [16]. If the patient is
in a confused state, then haloperidol may be administered
in a continuous infusion at a dose of 1–2mg/h, with an
initial bolus of 5mg.
For patients who experience disturbance in nocturnal sleep,
overnight sedation under controlled ventilation is recom-
mended, according to the plan described above [17].
The preferred analgesic regimen is a combination of a
nonsteroideal anti-inflammatory drug with morphine or
pethidine, administered parenterally. The recommended
plan is a fixed regimen combined with an ‘on-demand’
regimen if the patient is able to cooperate. In patients with
refractory pain, morphine administration at bolus doses of
1–2.5mg, subcutaneously or intravenously, via a patient-
controlled analgesia pump can achieve excellent results.
Pressure support ventilation
This form of ventilation is also considered partial support.
It was designed for use during weaning from mechanical
ventilation. Pressure support ventilation requires that the
patient is able to initiate breathing. If the patient is ade-
quately ventilated, with an appropriate degree of analge-
sia, then sedation is not generally required. In exceptional
cases, in which the patient presents with agitation result-
ing from a nonrespiratory cause, propofol or midazolam
may be administered at anxyolitic doses as was described
for synchronized intermittent mandatory ventilation (light
sedation; level 2 of the Ramsay scale or 13–15 points on
the GCSC) under close respiratory monitoring.
Continuous positive airway pressure
This mode of partial respiratory support is widely used
because of technical considerations, and in order to avoid
total respiratory substitution with controlled ventilation. It
also requires that the patient is able to initiate breathing.
Therefore, the recommendations are similar to those for
pressure support ventilation, described above.
Future strategies for selected patients
New evidence suggests that daily interruption of sedation in
selected patients may improve their situation by allowing clin-
icians to optimize the administration of sedatives while ensur-
ing optimal comfort for the patient [6]. A word of caution is
necessary regarding these findings, because this approach
is appropriate only for certain, stable patients. Further
research is necessary to confirm these findings in the
general population of ICU patients. However, these promis-
ing strategies might be an exciting prospect for the future.
Instruments to monitor neuromuscular blockade
The above-described scoring systems are not useful for
monitoring sedation in patients treated with muscular
blocking agents. Because these agents have a very low
margin of safety, they should be reserved for extreme situ-
ations in which the potential benefit to the patient justifies
their use. In such circumstances, we recommend discon-
tinuing their administration every 24 or 48h in order to
perform an accurate assessment of neuromuscular func-
tion. If this is not possible, an alternative can be to monitor
Critical Care    Vol 4 No 4 Carrasconeuromuscular function using a nerve stimulator [31]. The
purpose of this device is to provide sufficient stimuli to
produce action potentials in all fibres of a nerve. The sim-
plest way to stimulate nerves is to apply single stimuli at
intervals no shorter than 10s. Neuromuscular monitoring
offers the advantage of rapid response and objective data.
Conclusion
The present review describes and compares the available
instruments for monitoring ICU sedation, from a practical
and evidence-based point of view. Although many promis-
ing objective methods (measuring systems) are available,
there are no truly validated instruments for use in clinical
practice. AEPs can be used only for research in patients
with deep levels of sedation. Other measuring systems
require further development and validation before they can
be considered useful in ICU. Continuing research will
provide an objective system for improving the monitoring
and controlling of this essential treatment for ICU patients.
Subjective methods (scoring systems) that are based on
clinical observations have proven utility in guiding sedative
therapy. The GCSC achieves good face validity and relia-
bility, which assures its clinical utility for routine practice
and research. Other scales, in particular the Ramsay
scale, can be recommended for clinical use.
A conclusion that arises from the present review is that the
appropriate use of instruments to monitor sedation can
improve the sedative treatment that we deliver to our
patients. It is anticipated that future contributions to this
forgotten field will result in improvements in the quality of
care that our patients need and deserve.
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